{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:58:04Z","timestamp":1759683484375,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.psychres.2005.07.003","type":"journal-article","created":{"date-parts":[[2005,10,14]],"date-time":"2005-10-14T07:14:48Z","timestamp":1129274088000},"page":"131-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia"],"prefix":"10.1016","volume":"137","author":[{"given":"Neil","family":"Laufer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Maayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haggai","family":"Hermesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofi","family":"Marom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royi","family":"Gilad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rael","family":"Strous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2005.07.003_bib1","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.95.8.4089","article-title":"Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids","volume":"95","author":"Baulieu","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2005.07.003_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(03)00077-5","article-title":"Neurosteroid secretion in panic disorder","volume":"118","author":"Brambilla","year":"2003","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2005.07.003_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0074-7742(01)46061-2","article-title":"Role of the peripheral-type benzodiazepine receptor in adrenal and brain steroidogenesis","volume":"46","author":"Brown","year":"2001","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.psychres.2005.07.003_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004714-199312000-00008","article-title":"Treatment of social phobia with clonazepam and placebo","volume":"13","author":"Davidson","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"year":"1996","series-title":"Structured Clinical Interview for DMS-IV Axis I Disorders (SCID), Clinical Version: User's Guide","author":"First","key":"10.1016\/j.psychres.2005.07.003_bib5"},{"key":"10.1016\/j.psychres.2005.07.003_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0006-3223(98)00070-5","article-title":"Can the antidysphoric and aniolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3\u03b1, 5\u03b1-tetrahydroprogesterone availability?","volume":"44","author":"Guidotti","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib7","series-title":"ECDEU Assessment Manual for Psychopharmacology","article-title":"Clinical Global Impression Severity Scale","author":"Guy","year":"1976"},{"key":"10.1016\/j.psychres.2005.07.003_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0306-9877(97)90258-9","article-title":"Relationship of dehydroepiandrosterone and cortisol in disease","volume":"49","author":"Hechter","year":"1997","journal-title":"Medical Hypotheses"},{"year":"1995","series-title":"Social Phobia: Diagnosis, Assessment, and Treatment","author":"Heimberg","key":"10.1016\/j.psychres.2005.07.003_bib9"},{"key":"10.1016\/j.psychres.2005.07.003_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1017\/S0033291702005238","article-title":"Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia","volume":"32","author":"Heydari","year":"2002","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2005.07.003_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hup.304","article-title":"Glucocorticoids and cognitive function: from physiology to pathophysiology","volume":"16","author":"Jameison","year":"2001","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.psychres.2005.07.003_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0006-3223(97)00390-9","article-title":"Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia","volume":"43","author":"Johnson","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/00912709922007903","article-title":"DHEA and DHEA-S: a review","volume":"39","author":"Kroboth","year":"1999","journal-title":"Journal of Clinical Pharmacology"},{"year":"1996","series-title":"Mini International Neuropsychiatric Interview Version 4.4, Medical Outcomes System, Inc","author":"Lecrubier","key":"10.1016\/j.psychres.2005.07.003_bib14"},{"key":"10.1016\/j.psychres.2005.07.003_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/da.10064","article-title":"Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew","volume":"16","author":"Levin","year":"2002","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.psychres.2005.07.003_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Modern Problems of Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2826.2002.00861.x","article-title":"Functional subsets of serotonergic neurons: implications for control of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"14","author":"Lowry","year":"2002","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.psychres.2005.07.003_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000075334","article-title":"The influence of parturition on the level and synthesis of sulfated and free neurosteroids in rats","volume":"49","author":"Maayan","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2005.07.003_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02190407","article-title":"Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies","volume":"244","author":"Merikangas","year":"1995","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2005.07.003_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.155.7.910","article-title":"Effects of antidepressant treatment on neuroactive steroids in major depression","volume":"155","author":"Romeo","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0887-6185(89)90025-X","article-title":"Alcohol abuse in social phobia","volume":"3","author":"Schneier","year":"1989","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.psychres.2005.07.003_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/jnp.13.3.396","article-title":"Neuroactive steroid levels in patients with generalized anxiety disorder","volume":"13","author":"Semeniuk","year":"2001","journal-title":"Journal of Neuropsychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.psychres.2005.07.003_bib24","first-page":"148","article-title":"The Anxiety Disease","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.psychres.2005.07.003_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0091-3057(93)90128-G","article-title":"Stressor controllability, social interaction, and benzodiazepine systems","volume":"45","author":"Short","year":"1993","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1016\/j.psychres.2005.07.003_bib26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000064806","article-title":"Elevated blood levels of dehydroepiandrosterone sulphate vary with symptom load in posttraumatic stress disorder: findings from a longitudinal study of refugees in Sweden","volume":"71","author":"Sondergaard","year":"2002","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.psychres.2005.07.003_bib27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S0033291799002731","article-title":"Elevated circulatory level of GABA-antagonistic neurosteroids in patients with contact related postraumatic stress disorder","volume":"30","author":"Spivak","year":"2000","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2005.07.003_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.280.8.708","article-title":"Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial","volume":"280","author":"Stein","year":"1998","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.psychres.2005.07.003_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0006-3223(98)00328-X","article-title":"Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery","volume":"45","author":"Str\u00f6hle","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment","volume":"159","author":"Str\u00f6hle","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","article-title":"Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results","volume":"60","author":"Str\u00f6hle","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib32","first-page":"69","article-title":"Double-blind, placebo controlled comparison of clonazapam and alprazolam for panic disorder","volume":"52","author":"Tesar","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2005.07.003_bib33","first-page":"1272","article-title":"Serum dehydroepiandrosterone sulfate levels as an individual marker","volume":"79","author":"Thomas","year":"1994","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.psychres.2005.07.003_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0306-4530(01)00014-2","article-title":"Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation","volume":"26","author":"van Niekerk","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2005.07.003_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0165-0173(99)00021-1","article-title":"Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans","volume":"30","author":"Wolf","year":"1999","journal-title":"Brain Research Review"},{"key":"10.1016\/j.psychres.2005.07.003_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biological Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105002027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105002027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:18:52Z","timestamp":1759036732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178105002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0165178105002027"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2005.07.003","relation":{},"ISSN":["0165-1781"],"issn-type":[{"type":"print","value":"0165-1781"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2005.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}